Liverpool HEP iChart vs EACS
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Liverpool HEP iChart
This app helps healthcare professionals and patients identify potential drug-drug interactions between hepatitis medications and other drugs. It uses a "Traffic Light" system to indicate the recommendation for each interaction, providing a brief summary. The application is free and regularly updated with new data.
- Drug-drug interaction search
- Traffic Light system for recommendations
- Offline functionality
- Regular updates
- Summary of interactions
Read full descriptionHide full description
Description: Healthcare professionals and patients should use this application to search for potential drug-drug interactions between hepatitis drugs and other medications, as recommended by international treatment guidelines. Results are presented as a “Traffic Light” system (red, amber, green) to indicate the recommendation. A brief summary of each interaction is given. The application is available free of charge and has been developed by the Liverpool Drug Interactions Group at the University of Liverpool and Clubzap Ltd. Requirements: This is an “offline” application that is downloaded to your device. An internet connection is not required to use the application, but is needed for downloading updates. Why this application may be useful: In hepatitis therapy, patients take more than one hepatitis medication at a time and possibly other drugs to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different hepatitis drugs and other medications that the HCV- and/or HBV-infected patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.hep-druginteractions.org.
EACS
Read full descriptionHide full description
These Guidelines are developed by the European AIDS Clinical Society (EACS), a not-for-profit organization, whose mission is to promote excellence in standards of care, research and education in HIV-infection and related co-infections, and to actively engage in the formulation of public health policy, with the aim of reducing HIV disease burden across Europe. The EACS Guidelines provide guidance for healthcare professionals on: assessment of HIV-positive persons, antiretroviral therapy (ART), prevention and management of co-morbidities, co-infections and opportunistic infections. EACS App features include full text search, user-created bookmarks and notes, drug-drug interactions tables and more.
Screenshots
Verdict
The clearest difference is iOS requirement: Liverpool HEP iChart at 11.0 against EACS's 15.0. On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Liverpool HEP iChart ships an update every 3 months, EACS every 4 months. The most recent releases landed on November 1, 2026 and November 6, 2026 respectively.
| Parameter | Liverpool HEP iChart | EACS |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) — better | — |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 1 — better | — |
| Update frequency | Every 3 months — better | Every 4 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 11.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 12 MB | 44 MB |
| Age rating | 12+ | +17 |
| Developer | Liverpool Drug Interactions Group | Antimicrobial Therapy, Inc. |
In-app purchases
Liverpool HEP iChart
No in-app purchases
EACS
No in-app purchases








